Moneycontrol PRO
you are here: HomeNewsAutomobile

Workers at Ford's Tamil Nadu plant seek halt amid COVID-19 surge

The incident is the latest expression of discontent and reluctance among factory employees in the southern state, home to India's flourishing automobile industry, to work amid a surge in virus infections.

May 27, 2021 / 05:55 PM IST
Representative image

Representative image

Dozens of workers staged a lunchtime sit-in protest on Thursday at Ford Motor Co's plant in India's Tamil Nadu state, demanding paid leave and health benefits, three sources familiar with the matter said, as the country battles the coronavirus.

The incident is the latest expression of discontent and reluctance among factory employees in the southern state, home to India's flourishing automobile industry, to work amid a surge in virus infections.

COVID fallout: Hyundai shuts Tamil Nadu plant, Renault-Nissan workers protest over COVID-19 norms being flouted

Thursday's brief protest, which sources said did not affect production, came a day after the Chennai Ford Employees Union expressed concern over workers' safety in a letter sent to management after 230 workers caught the virus.

"The company should pay all medical expenses of workers affected by the coronavirus," the union said in Wednesday's letter, reviewed by Reuters, and called for the plant to be shut during a full lockdown in the state that runs until Monday.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

It also sought compensation of 10 million rupees ($137,890) each for the families of two workers who died of the virus. Ford did not immediately respond to a request for comment.

Other automakers in the state, such as South Korea's Hyundai Motor Co and France's Renault, as well as its alliance partner Nissan Motor Co, have halted production over workers' safety concerns as infections grow.

With more than 30,000 cases a day, Tamil Nadu is one of the states worst hit in India's second devastating wave of infections, but factories turning out automobiles are among those it has allowed to stay open during its lockdown.

Ford is in talks with the union and is considering a plan to bring forward a six-day maintenance shutdown it had planned, said one source familiar with the talks, adding that a final decision could come as soon as Thursday.

All the sources sought anonymity because they were not authorised to speak to the media. Ford has two car manufacturing plants in India to meet domestic and export needs.

The Tamil Nadu facility, with annual capacity of 200,000 units, makes the EcoSport and Endeavour sport-utility vehicles. The other, in the western state of Gujarat, can produce 240,000 cars a year.